Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
1.510
+0.180 (13.53%)
At close: Nov 6, 2026, 4:00 PM EST
1.520
+0.010 (0.66%)
After-hours: Nov 6, 2026, 7:50 PM EST
Equillium Employees
As of December 31, 2025, Equillium had 15 total employees, including 14 full-time and 1 part-time employees. The number of employees decreased by 20 or 57.14% compared to the previous year. That makes Equillium the 39,152nd largest employer in the world and 5,708th in the United States.
Employees
15
Change (1Y)
-20
Growth (1Y)
-57.14%
Revenue / Employee
n/a
Profits / Employee
-$1,200,600
Market Cap
118.33M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 15 | -20 | -57.14% | 14 | 1 |
| Dec 31, 2024 | 35 | -9 | -20.45% | 35 | 0 |
| Sep 30, 2024 | 45 | 0 | - | 45 | 0 |
| Jun 30, 2024 | 45 | -2 | -4.26% | 45 | 0 |
| Mar 31, 2024 | 44 | 7 | 18.92% | 44 | 0 |
| Dec 31, 2023 | 44 | 8 | 22.22% | 44 | 0 |
| Sep 30, 2023 | 45 | 0 | - | 45 | 0 |
| Jun 30, 2023 | 47 | 2 | 4.44% | 47 | 0 |
| Mar 31, 2023 | 37 | -10 | -21.28% | 37 | 0 |
| Dec 31, 2022 | 36 | -9 | -20.00% | 36 | 0 |
| Sep 30, 2022 | 45 | 0 | - | 45 | 0 |
| Jun 30, 2022 | 45 | - | - | 45 | 0 |
| Mar 31, 2022 | 47 | 16 | 51.61% | 47 | 0 |
| Dec 31, 2021 | 45 | 14 | 45.16% | 45 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 184 |
| Codexis | 146 |
| Coherus Oncology | 144 |
| Voyager Therapeutics | 141 |
| Molecular Partners AG | 134 |
| Inovio Pharmaceuticals | 112 |
| Nkarta | 106 |
| enGene Therapeutics | 82 |
EQ News
- 2 days ago - Equillium to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 12 days ago - Roth Capital says buy Equillium ahead of EQ504 readout - TheFly
- 12 days ago - Equillium doses first subject in Phase 1 trial of EQ504 - TheFly
- 12 days ago - Equillium Announces First Subject Dosed in Phase 1 Clinical Trial of EQ504 - GlobeNewsWire
- 26 days ago - Equillium assumed with an Outperform at Leerink - TheFly
- 4 weeks ago - Equillium Announces Poster Presentation at the 50th Anniversary La Jolla Immunology Conference - GlobeNewsWire
- 4 weeks ago - Equillium receives HREC clearance for EQ504 in Australia - TheFly
- 4 weeks ago - Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504 - GlobeNewsWire